Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR3 | P32745 | 1/20 | 0.50 |
| ▸ | TGM2 | P21980 | 1/20 | 0.46 |
| ▸ | CTSL | P07711 | 4/20 | 0.46 |
| ▸ | SIRT2 | Q8IXJ6 | 6/20 | 0.42 |
| ▸ | SIRT1 | Q96EB6 | 6/20 | 0.42 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.42 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18788631 | 0.81 | SSTR3 (0.65) | SSTR3CTSLHTR2A | |
| SCHEMBL18788630 | 0.81 | SSTR3 (0.65) | SSTR3CTSLHTR2A | |
| SCHEMBL18102693 | 0.79 | SSTR3 (0.51) | SSTR3CTSLSIRT2SIRT1SIRT3 | |
| SCHEMBL25361958 | 0.79 | SSTR3 (0.50) | SSTR3CTSLSIRT2SIRT1SIRT3 | |
| SCHEMBL25361946 | 0.79 | SSTR3 (0.50) | SSTR3CTSLSIRT2SIRT1SIRT3 | |
| SCHEMBL26015625 | 0.79 | SSTR3 (0.48) | SSTR3CTSLSIRT2SIRT1SIRT3 | |
| SCHEMBL16847750 | 0.79 | SIRT2 (0.44) | SSTR3TGM2CTSLSIRT2SIRT1 | |
| SCHEMBL29549580 | 0.78 | PTPN1 (0.42) | TGM2CTSLHTR2ACTSBPTPN1 | |
| SCHEMBL25361716 | 0.77 | PTPN1 (0.43) | SSTR3TGM2CTSLSIRT2SIRT1 | |
| SCHEMBL25361722 | 0.77 | PTPN1 (0.43) | SSTR3TGM2CTSLSIRT2SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250170256-A1 | THERAPEUTIC ANTIBODY AND USES THEREOF | MULTITUDE THERAPEUTICS INC. (CN) | 2025-05-29 | — | — | US | disclosed |
| US-20240010743-A1 | THERAPEUTIC ANTIBODY AND USES THEREOF | MULTITUDE THERAPEUTICS INC. (CN) | 2024-01-11 | — | — | US | disclosed |
| CN-112105643-B | Therapeutic antibodies and uses thereof | 普众发现医药科技(上海)有限公司 | 2023-09-26 | — | — | CN | disclosed |
| EP-4204452-A1 | THERAPEUTIC ANTIBODY AND USES THEREOF | Multitude Inc. (CN) | 2023-07-05 | — | — | EP | disclosed |
| CN-116323678-A | Therapeutic antibodies and uses thereof | 普众发现医药科技(上海)有限公司 | 2023-06-23 | — | — | CN | disclosed |